MHRA and NICE invite early adopters to trial accelerated aligned pathway – six months ahead of schedule

MHRA and NICE invite early adopters to trial accelerated aligned pathway – six months ahead of schedule

MHRA and NICE invite early adopters to trial accelerated aligned pathway – six months ahead of schedule

Aligned pathway will streamline decisions on licensing and value for medicines, helping patients to benefit from them sooner.

HM GovernmentSource

Previus Post
New registration
Next Post
Stocks Go

Leave a comment